Antiviral prescriptions to U.S. ambulatory care visits with a diagnosis of influenza before and after high level of adamantane resistance 2005-06 season

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Hsieh, Yu Hsiang ^a   Chen, Kuan Fu ^a,b   Gaydos, Charlotte A ^a   Rothman, Richard E ^a   Kelen, Gabor D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; AMANTADINE; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTIVIRAL RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HEALTH SURVEY; HUMAN; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRESCRIPTION; SCHOOL CHILD; UNITED STATES;

ADAMANTANE; ADOLESCENT; ADULT; AMBULATORY CARE; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SEASONS; UNITED STATES; YOUNG ADULT;

INFLUENZA A VIRUS;

EID: 77952482539     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008945     Document Type: Article

References (20)

1. Linder J, Bates D, Platt R (2005) Antivirals and antibiotics for influenza in the United States, 1995-2002. Pharmacoepidemiol Drug Saf 14: 531-536.
2. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood F, Jain S, Finelli L, Shaw M, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
3. Bright R, Shay D, Shu B, Cox N, Klimov A (2006) Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295(298): 891-294.
4. Centers for Disease Control and Prevention (CDC) (2006) High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents - United States, 2005-06 influenza season. MMWR Morb Mortal Wkly Rep 55: 44-46.
5. Dharan N, Gubareva L, Meyer J, Okomo-Adhiambo M, McClinton R, et al. (2009) Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 301: 1034-1041.
6. Centers for Disease Control and Prevention (CDC) (2008) Interim Recommendations for the Use of Influenza Antiviral Medications in the Setting of Oseltamivir Resistance among Circulating Influenza A (H1N1) Viruses, 2008-09 Influenza Season. http://www.cdc.gov/flu/professionals/antivirals/ recommendations.htm. Accessed February 12, 2009.
7. Centers for Disease Control and Prevention (CDC) (2009) Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep 58: 433-435.
8. World Health Organization (2009) Antiviral use and the risk of drug resistance - Pandemic (H1N1) 2009 briefing note 12. http://www.who.int/csr/ disease/swineflu/notes/h1n1-antiviral-use-20090925/en/index.html. Accessed September 25, 2009.
9. Health Alert Network (2006) CDC Recommends against the Use of Amantadine and Rimantadine for the Treatment or Prophylaxis of Influenza in the United States during the 2005-06 Influenza Season.: Centers for Disease Control and Prevention. http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum =00240. Accessed December 14, 2009.
10. Kane B, Degutis L, Sayward H, D'Onofrio G (2004) Compliance with the Centers for Disease Control and Prevention recommendations for the diagnosis and treatment of sexually transmitted diseases. Acad Emerg Med 11: 371-377.
11. Vanderweil S, Pelletier A, Hamedani A, Gonzales R, Metlay J, et al. (2007) Declining antibiotic prescriptions for upper respiratory infections, 1993-2004. Acad Emerg Med 14: 366-369.
12. Tracy C, Costabile R (2009) The evaluation and treatment of acute epididymitis in a large university based population: are CDC guidelines being followed? World J Urol 27: 259-263.
13. Magid D, Stiffman M, Anderson L, Irwin K, Lyons E (2003) Adherence to CDC STD guideline recommendations for the treatment of Chlamydia trachomatis infection in two managed care organizations. Sex Transm Dis 30: 30-32.
14. Grijalva C, Nuorti J, Griffin M (2009) Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 302: 758-766.
15. National Center for Health Statistics (2007) The National Ambulatory Medical Care Survey (NAMCS) Description. http://www.cdc.gov/nchs/about/major/ ahcd/nhamcsds.htm. Accessed September 17, 2008.
16. Hsieh Y-H, Rothman R, Newman-Toker D, Kelen G (2008) National estimation of rates of HIV serology testing in US emergency departments 1993-2005: baseline prior to the 2006 Centers for Disease Control and Prevention recommendations. AIDS 22: 2127-2134.
17. McCaig L, Woodwell D (2006) Analyzing data from the NAMCS and the NHAMCS.: CDC/National Center for Health Statistics. http://www.cdc.gov/nchs/ ahcd/ahcd-presentations.htm. Accessed December 17, 2009.
18. Bright R, Medina M, Xu X, Perez-Oronoz G, Wallis T, et al. (2005) Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366: 1175-1181.
19. Ozdas A, Speroff T, Waitman L, Ozbolt J, Butler J, et al. (2006) Integrating "best of care" protocols into clinicians' workflow via care provider order entry: impact on quality-of-care indicators for acute myocardial infarction. J Am Med Inform Assoc 13: 188-196.
20. Asaro P, Sheldahl A, Char D (2006) Embedded guideline information without patient specificity in a commercial emergency department computerized orderentry system. Acad Emerg Med 13: 452-458.